Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RaproCell for Chemotherapy Side Effects
NCT05137067Phase 2Completed
- Sponsor
- Optimal Health Research
- Start
- Jan 2021
- Primary completion
- Oct 2022
- Countries
- 1
01
Overview
Phase 2, randomised trial (9 arms), sponsored by Optimal Health Research. Primary endpoints: PROMIS Global 10 Health Questionnaire at 3 months and Symptom Assessment Questionnaire at 3 months. Started Jan 2021; status: completed.
Beyond the preview
Go deeper on NCT05137067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05137067.